TY - JOUR AU - Bray, F. AU - Ferlay, J. AU - Soerjomataram, I. AU - Siegel, R. L. AU - Torre, L. A. AU - Jemal, A. PY - 2018 DA - 2018// TI - Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries JO - CA Cancer J Clin VL - 68 ID - Bray2018 ER - TY - STD TI - Fact Sheets by Population-Globocan-IARC [Internet]. http://globocan.iarc.fr/Pages/fact sheets population.aspx.. UR - http://globocan.iarc.fr/Pages/fact ID - ref2 ER - TY - JOUR PY - 2018 DA - 2018// TI - EASL clinical practice guidelines: management of hepatocellular carcinoma JO - J Hepatol VL - 69 UR - https://doi.org/10.1016/j.jhep.2018.03.019 DO - 10.1016/j.jhep.2018.03.019 ID - ref3 ER - TY - JOUR AU - Marrero, J. A. AU - Kulik, L. M. AU - Sirlin, C. B. PY - 2018 DA - 2018// TI - Diagnosis, staging, and Management of Hepatocellular Carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases JO - Hepatology. VL - 68 UR - https://doi.org/10.1002/hep.29913 DO - 10.1002/hep.29913 ID - Marrero2018 ER - TY - JOUR AU - Forner, A. AU - Reig, M. AU - Bruix, J. PY - 2018 DA - 2018// TI - Hepatocellular carcinoma JO - Lancet. VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30010-2 DO - 10.1016/S0140-6736(18)30010-2 ID - Forner2018 ER - TY - JOUR AU - Varela, M. AU - Real, M. I. AU - Burrel, M. PY - 2007 DA - 2007// TI - Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics JO - J Hepatol VL - 46 UR - https://doi.org/10.1016/j.jhep.2006.10.020 DO - 10.1016/j.jhep.2006.10.020 ID - Varela2007 ER - TY - JOUR AU - Poon, R. T. AU - Tso, W. K. AU - Pang, R. W. PY - 2007 DA - 2007// TI - A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead JO - Clin Gastroenterol Hepatol VL - 5 UR - https://doi.org/10.1016/j.cgh.2007.04.021 DO - 10.1016/j.cgh.2007.04.021 ID - Poon2007 ER - TY - JOUR AU - Lammer, J. AU - Malagari, K. AU - Vogl, T. PY - 2010 DA - 2010// TI - Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study JO - Cardiovasc Intervent Radiol VL - 33 UR - https://doi.org/10.1007/s00270-009-9711-7 DO - 10.1007/s00270-009-9711-7 ID - Lammer2010 ER - TY - JOUR AU - Golfieri, R. AU - Giampalma, E. AU - Renzulli, M. PY - 2014 DA - 2014// TI - Randomised controlled trial of doxorubicin-eluting beads vs. conventional chemoembolisation for hepatocellular carcinoma JO - Br J Cancer VL - 111 UR - https://doi.org/10.1038/bjc.2014.199 DO - 10.1038/bjc.2014.199 ID - Golfieri2014 ER - TY - JOUR AU - Kim, N. H. AU - Lee, T. AU - Cho, Y. K. AU - Kim, B. I. AU - Kim, H. J. PY - 2018 DA - 2018// TI - Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization JO - J Gastroenterol Hepatol VL - 33 UR - https://doi.org/10.1111/jgh.14083 DO - 10.1111/jgh.14083 ID - Kim2018 ER - TY - JOUR AU - Sieghart, W. AU - Hucke, F. AU - Pinter, M. PY - 2013 DA - 2013// TI - The ART of decision making: retreatment with Transarterial chemoembolization in patients with hepatocellular carcinoma JO - Hepatology. VL - 57 UR - https://doi.org/10.1002/hep.26256 DO - 10.1002/hep.26256 ID - Sieghart2013 ER - TY - JOUR AU - Kadalayil, L. AU - Benini, R. AU - Pallan, L. PY - 2013 DA - 2013// TI - A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt247 DO - 10.1093/annonc/mdt247 ID - Kadalayil2013 ER - TY - JOUR AU - Adhoute, X. AU - Penaranda, G. AU - Naude, S. PY - 2015 DA - 2015// TI - Retreatment with DEB-TACE: the ABCR SCORE, an aid to the decision-making process JO - J Hepatol VL - 62 UR - https://doi.org/10.1016/j.jhep.2014.11.014 DO - 10.1016/j.jhep.2014.11.014 ID - Adhoute2015 ER - TY - JOUR AU - Cabibbo, G. AU - Enea, M. AU - Attnasio, M. AU - Bruix, J. AU - Craxì, A. AU - Cammà, C. PY - 2010 DA - 2010// TI - A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma JO - Hepatology. VL - 51 UR - https://doi.org/10.1002/hep.23485 DO - 10.1002/hep.23485 ID - Cabibbo2010 ER - TY - JOUR AU - García-Tsao, G. AU - Abraldes, J. G. AU - Berzigotti, A. AU - Bosch, J. PY - 2017 DA - 2017// TI - Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases JO - Hepatology. VL - 65 UR - https://doi.org/10.1002/hep.28906 DO - 10.1002/hep.28906 ID - García-Tsao2017 ER - TY - JOUR AU - Prajapati, H. J. AU - Xing, M. AU - Spivey, J. R. PY - 2014 DA - 2014// TI - Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads DEB-TACE chemoembolization in patients with unresectable HCC JO - AJR Am J Roentgenol VL - 203 UR - https://doi.org/10.2214/AJR.13.12308 DO - 10.2214/AJR.13.12308 ID - Prajapati2014 ER - TY - JOUR AU - Lencioni, R. AU - Llovet, J. M. PY - 2010 DA - 2010// TI - Modified RECIST (mRECIST) assessment for hepatocellular carcinoma JO - Semin Liver Dis VL - 30 UR - https://doi.org/10.1055/s-0030-1247132 DO - 10.1055/s-0030-1247132 ID - Lencioni2010 ER - TY - JOUR AU - Forner, A. AU - Gilabert, M. AU - Bruix, J. AU - Raoul, J. L. PY - 2014 DA - 2014// TI - Treatment of intermediate-stage hepatocellular carcinoma JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.122 DO - 10.1038/nrclinonc.2014.122 ID - Forner2014 ER - TY - JOUR AU - Berzigotti, A. AU - Reig, M. AU - Abraldes, J. G. AU - Bosch, J. AU - Bruix, J. PY - 2015 DA - 2015// TI - Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis JO - Hepatology. VL - 61 UR - https://doi.org/10.1002/hep.27431 DO - 10.1002/hep.27431 ID - Berzigotti2015 ER - TY - JOUR AU - Choi, J. W. AU - Chung, J. W. AU - Lee, D. H. PY - 2018 DA - 2018// TI - Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma JO - Eur Radiol VL - 28 UR - https://doi.org/10.1007/s00330-017-5145-9 DO - 10.1007/s00330-017-5145-9 ID - Choi2018 ER - TY - JOUR AU - Malagari, K. AU - Pomoni, M. AU - Moschouris, H. PY - 2012 DA - 2012// TI - Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: five-year survival analysis JO - Cardiovasc Intervent Radiol VL - 35 UR - https://doi.org/10.1007/s00270-012-0394-0 DO - 10.1007/s00270-012-0394-0 ID - Malagari2012 ER - TY - JOUR AU - Burrel, M. AU - Reig, M. AU - Forner, A. PY - 2012 DA - 2012// TI - Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (DEB-TACE) using drug eluting beads. Implications for clinical practice and trial design JO - J Hepatol VL - 56 UR - https://doi.org/10.1016/j.jhep.2012.01.008 DO - 10.1016/j.jhep.2012.01.008 ID - Burrel2012 ER - TY - JOUR AU - Terzi, E. AU - Terenzi, L. AU - Venerandi, L. AU - Croci, L. PY - 2014 DA - 2014// TI - The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series JO - Dig Dis VL - 32 UR - https://doi.org/10.1159/000368007 DO - 10.1159/000368007 ID - Terzi2014 ER - TY - JOUR AU - Chen, L. AU - Ni, C. F. AU - Chen, S. X. PY - 2016 DA - 2016// TI - A modified model for assessment for retreatment with Transarterial chemoembolization in Chinese hepatocellular carcinoma patients JO - J Vasc Interv Radiol VL - 27 UR - https://doi.org/10.1016/j.jvir.2015.12.016 DO - 10.1016/j.jvir.2015.12.016 ID - Chen2016 ER - TY - JOUR AU - Facciorusso, A. AU - Mariani, L. AU - Sposito, C. PY - 2016 DA - 2016// TI - Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma JO - J Gastroenterol Hepatol VL - 31 UR - https://doi.org/10.1111/jgh.13147 DO - 10.1111/jgh.13147 ID - Facciorusso2016 ER - TY - JOUR AU - Pipa-Muñiz, M. AU - Castells, L. AU - Pascual, S. PY - 2017 DA - 2017// TI - The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish study JO - Gastroenterol Hepatol VL - 40 UR - https://doi.org/10.1016/j.gastrohep.2017.05.009 DO - 10.1016/j.gastrohep.2017.05.009 ID - Pipa-Muñiz2017 ER - TY - JOUR AU - Zhang, Y. Q. AU - Jiang, L. J. AU - Wen, J. PY - 2018 DA - 2018// TI - Comparison of α-fetoprotein criteria and modified response evaluation criteria in solid tumors for the prediction of overall survival of patients with hepatocellular carcinoma after Transarterial chemoembolization JO - J Vasc Interv Radiol VL - 29 UR - https://doi.org/10.1016/j.jvir.2018.07.031 DO - 10.1016/j.jvir.2018.07.031 ID - Zhang2018 ER - TY - JOUR AU - Biolato, M. AU - Gallusi, G. AU - Iavarone, M. PY - 2018 DA - 2018// TI - Prognostic ability of BCLC-B subclassification in patients with hepatocellular carcinoma undergoing Transarterial chemoembolization JO - Ann Hepatol VL - 17 UR - https://doi.org/10.5604/01.3001.0010.7542 DO - 10.5604/01.3001.0010.7542 ID - Biolato2018 ER - TY - JOUR AU - Sánchez-Delgado, J. AU - Vergara, M. AU - Machlab, S. PY - 2018 DA - 2018// TI - Analysis of survival and prognostic factors in treatment of hepatocellular carcinoma in Spanish patients with drug-eluting bead transarterial chemoembolization JO - Eur J Gastroenterol Hepatol VL - 30 UR - https://doi.org/10.1097/MEG.0000000000001229 DO - 10.1097/MEG.0000000000001229 ID - Sánchez-Delgado2018 ER - TY - JOUR AU - Moreau, R. AU - Jalan, R. AU - Ginés, P. PY - 2013 DA - 2013// TI - Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis JO - Gastroenterology. VL - 144 UR - https://doi.org/10.1053/j.gastro.2013.02.042 DO - 10.1053/j.gastro.2013.02.042 ID - Moreau2013 ER - TY - JOUR AU - Shah, N. D. AU - Ventura-Cots, M. AU - Abraldes, J. G. PY - 2019 DA - 2019// TI - Alcohol related Liver Disease is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide JO - Clin Gastroenterol Hepatol VL - S1542–3565 ID - Shah2019 ER - TY - JOUR AU - Marot, A. AU - Henrion, J. AU - Knebel, J. F. AU - Moreno, C. AU - Deltenre, P. PY - 2017 DA - 2017// TI - Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fattyliver disease among patients with cirrhosis: an observational study JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0186715 DO - 10.1371/journal.pone.0186715 ID - Marot2017 ER - TY - JOUR AU - Adhoute, X. AU - Pénaranda, G. AU - Raoul, J. L. PY - 2017 DA - 2017// TI - Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort JO - World J Gastroenterol VL - 23 UR - https://doi.org/10.3748/wjg.v23.i14.2545 DO - 10.3748/wjg.v23.i14.2545 ID - Adhoute2017 ER - TY - JOUR AU - Collette, S. AU - Bonnetain, F. AU - Paoletti, X. PY - 2008 DA - 2008// TI - Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials JO - Ann Oncol VL - 19 UR - https://doi.org/10.1093/annonc/mdn030 DO - 10.1093/annonc/mdn030 ID - Collette2008 ER - TY - JOUR AU - Ricke, J. AU - Klümpen, H. J. AU - Amthauer, H. PY - 2019 DA - 2019// TI - Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma JO - J Hepatol VL - 71 UR - https://doi.org/10.1016/j.jhep.2019.08.006 DO - 10.1016/j.jhep.2019.08.006 ID - Ricke2019 ER - TY - JOUR AU - Chen, Z. H. AU - Zhang, X. P. AU - Cai, X. R. PY - 2018 DA - 2018// TI - The predictive value of albumin-to-alkaline phosphatase ratio for overall survival of hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy JO - J Cancer VL - 9 UR - https://doi.org/10.7150/jca.26120 DO - 10.7150/jca.26120 ID - Chen2018 ER - TY - JOUR AU - Wu, X. AU - Chen, R. AU - Zheng, W. PY - 2018 DA - 2018// TI - Comprehensive analysis of factors affecting clinical response and short-term survival to drug-eluting bead Transarterial chemoembolization for treatment in patients with liver Cancer JO - Technol Cancer Res Treat VL - 17 ID - Wu2018 ER -